RePORT International Resources

Unitaid supports in making new health products available and affordable for people in low- and middle-income countries. It identifies innovative treatments, tests and tools, help tackle the market barriers that are holding them back, and get them to the people who need them most – fast. It provides health partners with financial grants to accelerate innovation in global health.

The VALIDATE Network aims to accelerate vaccine research and development for three groups of complex neglected intracellular pathogens that cause significant mortality and morbidity throughout the world, particularly in low-and-middle-income countries (LMICs): Mycobacteria (causing tuberculosis, leprosy and other diseases), Leishmania (causing leishmaniasis) and Burkholderia pseudomallei (causing melioidosis). A second, important aim of the VALIDATE Network is to facilitate career progression for its members, particularly Early Career Researchers (ECRs), and (recognising career progression inequity) researchers from LMICs and researchers identifying as female and/or non-binary. CALL FOR ROUND 6 AWARDS IS EXPECTED IN DECEMBER 2025

APPLICATION DEADLINE: 19 October, 2025 The Harvard Global Health Institute is now accepting applications for our 2025-2026 cohort of Visiting Research Scholarship Program. Applications must be submitted by a Harvard faculty member, who will serve as the sponsor for an international research collaborator. This program provides funding for the Harvard sponsor to host their collaborator for a 6-week in-residence experience to complement ongoing research activities. Visiting scholars will have their in-residence time on campus financially covered through the fellowship award. Scholars will be provided with a lump sum stipend for their logistical expenses related to the visit (i.e. housing, flights to and from Cambridge, health insurance, J-1 visa fees, and daily per diem for food). The Harvard sponsor must be a Harvard faculty member at any school or affiliated hospital, and the visiting scholar should have a doctoral degree in a relevant degree. Demonstrated evidence of significant collaborative work with the sponsor, or the foundations for significant collaborative work, is required. This could be publications of peer-reviewed manuscripts, codeveloped educational curricula, partnership on policy, or service work.

This monthly webinar series covers the research and publishing process. Featuring Sage and external speakers from various disciplines, this series addresses the stumbling blocks every researcher encounters at the beginning of their careers and provides practical and in-depth guidance to help get published. For more information and to register for each webinar, click the links below. All webinars occur at 8 am PT/11 am ET/5 pm CET. You can also watch recordings of the previous webinars in the series by scrolling down to our webinar library, where you can find links to all the recordings and topics available at your fingertips anytime, anywhere.

Application deadline: 20 November 2025 This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing. Please refer to the website for details

Dealine for New Application: 25 November, 2025 This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme. The applications are opened 3 times a year

Wellcome - Grants and Fundings - Searchable Database

This learning platform is custom-built to host high-quality courses developed by the WHO Academy, along with a wide range of quality-approved content from trusted providers. It offers personalized learning pathways, interactive tools, and collaborative features.

This website provides access to the latest WHO recommendations on all aspects of tuberculosis prevention and care. The user can search, filter and cross-tabulate the recommendations through built-in functions. For each individual recommendation one can also access key background information, such as the evidence summaries and the Guideline Development Group decisions underpinning it.

This call to action accompanies the consensus statement on the optimal and early inclusion of pregnant and lactating women in tuberculosis research and specifies the actions that need to be taken to ensure full implementation of the agreed approaches in the statement. The target audience includes product developers and industry, study sponsors, funding agencies, researchers and research networks, regulatory authorities, institutional review boards (IRBs) and ethics committees, national TB and maternal and child health programmes, civil society organizations and affected communities, and health care providers.

In 2024, the WHO Global Programme on Tuberculosis & Lung Health led a consensus building process to advance the earlier and optimal inclusion of pregnant women in TB research. The process is aligned with broader global developments to transform clinical trial practices, including addressing the needs of underrepresented populations. This consensus statement summarizes the consensus process, which included five thematic working groups (covering preclinical TB research, TB therapeutics research, TB vaccine research, maternal TB surveillance systems and advocacy), evidence reviews to address gaps in data and knowledge and a consensus meeting in February 2025. The approaches to earlier and optimal inclusion arising from the consensus process include crosscutting actions as well as approaches specific to each working group theme.

The WHO TB Patient Cost Survey resources include a standardized household questionnaire (2025 version) for collecting data on the economic impact of TB, along with companion STATA datasets and code to support data entry, management, and analysis. These tools are designed to promote consistent methodology and facilitate cross-country comparisons in TB research and program evaluation.